Dr Follows gives a good introduction into the commonest leukaemia in the western world, CLL. He then covers advances in laboratory analysis of CLL , supportive care and then goes on to discuss current treatments first line, relapsed cll and results for various trials presented at ASH 2018.
Who we are
We are a patient led UK charity, our mission is to support and empower CLL patients, their families and their carers.
Read moreOur 24 hour membership telephone number is: 0800 977 4396
About CLL
CLL is a malignancy of B lymphocytes, one of several types of cells of the immune system.
Read moreAbout CLL
Donate
Donate to support our CLL community
Donate nowHealthUnlocked
Connect to others who understand
Open in a new tabThis page was last reviewed 22nd October 2019. Next review October 2022
Send us feedback about this page
